Invention Grant
- Patent Title: Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXI
- Patent Title (中): 鉴定增强血液凝固依赖于FXI的非抗凝血硫酸多糖的方法
-
Application No.: US13002501Application Date: 2009-08-21
-
Publication No.: US08546096B2Publication Date: 2013-10-01
- Inventor: Michael Dockal , Friedrich Scheiflinger , Peter Turecek
- Applicant: Michael Dockal , Friedrich Scheiflinger , Peter Turecek
- Applicant Address: US IL Deerfield CH Glattpark (Opfikon)
- Assignee: Baxter International Inc.,Baxter Healthcare S.A.
- Current Assignee: Baxter International Inc.,Baxter Healthcare S.A.
- Current Assignee Address: US IL Deerfield CH Glattpark (Opfikon)
- Agency: Bozicevic, Field & Francis LLP
- Agent Bret E. Field; Khin K. Chin
- International Application: PCT/EP2009/006082 WO 20090821
- International Announcement: WO2010/020423 WO 20100225
- Main IPC: C12Q1/56
- IPC: C12Q1/56

Abstract:
A method of identifying a non-anticoagulant sulfated polysaccharide (NASP) which is capable of enhancing blood coagulation in dependence of FXI, the method comprising: a) combining a blood or plasma sample having activation competent FXI with a sulfated polysaccharide and measuring the clotting or thrombin generation parameters of the blood or plasma sample; b) combining a corresponding blood or plasma sample deficient In activation competent FXI with a sulfated polysaccharide and measuring the clotting or thrombin generation parameters of the blood or plasma sample and c) comparing the clotting or thrombin generation parameters of the blood or plasma samples as determined in steps (a) and (b) with each other.
Public/Granted literature
- US20110110921A1 Methods for Treating Bleeding Disorders Public/Granted day:2011-05-12
Information query